Your browser doesn't support javascript.
loading
Impact of body mass index (BMI) on the efficacy of plerixafor for hematopoietic progenitor cell (HPC) mobilization.
Yingling, Spencer K; Gonzalez, Rebecca M; Dillaman, Megan; Seago, Kelsea; Wen, Sijin; Ross, Kelly G; Veltri, Lauren; Cumpston, Aaron.
Afiliação
  • Yingling SK; Department of Pharmacy, West Virginia University Medicine, Morgantown, WV, USA. spencer.yingling.m@wvumedicine.org.
  • Gonzalez RM; Osborn Hematopoietic Malignancy and Transplantation Program, MBRCC, West Virginia University, Morgantown, WV, USA. spencer.yingling.m@wvumedicine.org.
  • Dillaman M; Department of Pharmacy, West Virginia University Medicine, Morgantown, WV, USA.
  • Seago K; Department of Pharmacy, Moffitt Cancer Center, Tampa, FL, USA.
  • Wen S; Department of Pharmacy, West Virginia University Medicine, Morgantown, WV, USA.
  • Ross KG; Osborn Hematopoietic Malignancy and Transplantation Program, MBRCC, West Virginia University, Morgantown, WV, USA.
  • Veltri L; Department of Pharmacy, West Virginia University Medicine, Morgantown, WV, USA.
  • Cumpston A; Osborn Hematopoietic Malignancy and Transplantation Program, MBRCC, West Virginia University, Morgantown, WV, USA.
Bone Marrow Transplant ; 57(7): 1194-1197, 2022 07.
Article em En | MEDLINE | ID: mdl-35468948

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mobilização de Células-Tronco Hematopoéticas / Compostos Heterocíclicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mobilização de Células-Tronco Hematopoéticas / Compostos Heterocíclicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article